Vericel Corporation
Clinical trials sponsored by Vericel Corporation, explained in plain language.
Cell therapy company developing treatments for sports injuries and burns.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New cartilage implant aims to outperform microfracture for ankle injuries
Disease control Recruiting nowThis Phase 3 trial tests whether a lab-grown cartilage implant (MACI) can better repair painful ankle cartilage defects than the standard microfracture procedure. About 309 adults aged 17-65 with ankle cartilage damage will be randomly assigned to receive either MACI or microfrac…
Phase 3 • Sponsor: Vericel Corporation • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New cartilage patch could help teens with knee damage avoid Long-Term pain
Disease control Recruiting nowThis study tests whether a lab-grown cartilage implant (MACI) works better than a standard surgery (microfracture) for teens aged 10-17 with knee cartilage damage. About 45 participants will receive either treatment and be followed for improvements in pain and sports function. Th…
Phase 3 • Sponsor: Vericel Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC